Directs behavioral health agencies to submit policies to the Department of Health (Department) related to the transfer or discharge of a person without the person's consent and requires the Department to adopt a model policy based on the policies that it receives.
Requires certain behavioral health agencies to provide patients seeking treatment for opioid use disorder or alcohol use disorder with education related to clinically appropriate pharmacological treatment options.
Requires the length of an initial authorization for inpatient or residential substance use disorder treatment approved by the Public Employees Benefits Board (PEBB), private health insurers, and Medicaid managed care organizations to be no less than 14 days from the date of admission.
Requires the PEBB, private health insurers, and Medicaid managed care organizations to reimburse hospitals and psychiatric hospitals that bill on an outpatient basis for opioid overdose reversal medications dispensed or distributed to a patient and for the administration of long-acting injectable buprenorphine.
Directs the Health Care Authority (Authority) to convene a work group of commercial health carriers, Medicaid managed care organizations, and behavioral health agencies to develop recommendations for streamlining the requirements and processes for the authorization and reauthorization of inpatient or residential substance use disorder treatment.
Directs the Authority to conduct a gap analysis of nonemergency transportation benefits for Medicaid enrollees.
From the Second Substitute House Bill Report (2SSB 6228), written by the Legislature's nonpartisan staff. Read the full report ↗